Related Experiment Video
Updated: Aug 4, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
A Deletion in Duchenne Muscular Dystrophy Gene Found Through Whole Exome Sequencing in Iran
Saman Ameri-Mahabadi1,2, Ali Nikfar2,3,4, Mojdeh Mansouri3
1Student Research Committee, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Abstract:
Duchenne muscular dystrophy (DMD) is a severe progressive X-linked neuromuscular illness that affects movement through mutations in dystrophin gene. The mutation leads to insufficient, lack of, or dysfunction of dystrophin. The cause of DMD was determined in an Iranian family. Exome sequencing was carried out along with a complete physical examination of the family. In silico methods were applied to find the alteration in the protein structure. The homozygous variant in DMD gene (NM-004006.2) was defined as c.2732-2733delTT (p.Phe911CysfsX8) in exon 21. In addition, phylogenetic conservation study of the human dystrophin protein sequence revealed that phenylalanine 911 is one of the evolutionarily conserved amino acids. In conclusion, our study indicated a new deletion in the DMD gene in the affected family. This deletion with an X-linked inheritance pattern is new in Iran. These findings could facilitate genetic counseling for this family and other patients in the future.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Animal Mitochondrial Genetics

